Furthermore, we treated 4 AML fresh BMMNCs with graduate increased dosage of DAC, and found that DAC also promoted mRNA expression of SLC22A3 in the same dose range (Fig. 4G–J), which further verify our thesis that DNA methylation regulates SLC22A3 mRNA expression in AML. Here, SLC22A3 is linked to acute myeloid leukemia.